Impact of molecular profiling on overall survival of patients with advanced ovarian cancer.
about
Is ovarian cancer a targetable disease? A systematic review and meta-analysis and genomic data investigationStrandAdvantage test for early-line and advanced-stage treatment decisions in solid tumors.Protein drug target activation homogeneity in the face of intra-tumor heterogeneity: implications for precision medicine.Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers.Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes.Value-based genomics.
P2860
Impact of molecular profiling on overall survival of patients with advanced ovarian cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of molecular profiling ...... with advanced ovarian cancer.
@en
Impact of molecular profiling ...... with advanced ovarian cancer.
@nl
type
label
Impact of molecular profiling ...... with advanced ovarian cancer.
@en
Impact of molecular profiling ...... with advanced ovarian cancer.
@nl
prefLabel
Impact of molecular profiling ...... with advanced ovarian cancer.
@en
Impact of molecular profiling ...... with advanced ovarian cancer.
@nl
P2093
P2860
P356
P1433
P1476
Impact of molecular profiling ...... with advanced ovarian cancer.
@en
P2093
Andreas Voss
David Spetzler
Ken Burnett
Matthew Powell
Michael Friedlander
Robert Burger
Sandeep Reddy
Thomas J Herzog
Thomas Krivak
P2860
P304
19840-19849
P356
10.18632/ONCOTARGET.7835
P407
P577
2016-03-01T00:00:00Z